Trial · NCT01340482
Results by group43
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 43
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Safety and Efficacy of Repeated SC Injections of KRN23 | KRN23 | Subjects reporting at least one TEAE | 24 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | Bone Substudy KRN23 | Subjects reporting at least one TEAE | 1 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | Bone Substudy Placebo | Subjects reporting at least one TEAE | 1 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | KRN23 | Subjects who died | 0 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | Bone Substudy KRN23 | Subjects who died | 0 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | Bone Substudy Placebo | Subjects who died | 0 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | KRN23 | Subjects reporting SAE other than death | 0 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | Bone Substudy KRN23 | Subjects reporting SAE other than death | 0 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | Bone Substudy Placebo | Subjects reporting SAE other than death | 0 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | KRN23 | Subjects reporting at least one DLT | 0 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | Bone Substudy KRN23 | Subjects reporting at least one DLT | 0 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | Bone Substudy Placebo | Subjects reporting at least one DLT | 0 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | KRN23 | Subjects reporting AE leading to discontinuation | 1 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | Bone Substudy KRN23 | Subjects reporting AE leading to discontinuation | 0 | Participants | |
| Safety and Efficacy of Repeated SC Injections of KRN23 | Bone Substudy Placebo | Subjects reporting AE leading to discontinuation | 0 | Participants | |
| Evaluation of Effect of Repeated SC Injections of KRN23 | KRN23 | Visit 2 (D0)/0 | 1.89 | Full Range 1.2 to 2.8 | mg/dL |
| Evaluation of Effect of Repeated SC Injections of KRN23 | KRN23 | Visit 3 (D3)/3 | 2.18 | Full Range 1.5 to 2.9 | mg/dL |
| Evaluation of Effect of Repeated SC Injections of KRN23 | KRN23 | Visit 4 (D7)/7 | 2.20 | Full Range 1.7 to 3.2 | mg/dL |
| Evaluation of Effect of Repeated SC Injections of KRN23 | KRN23 | Visit 5 (D12)/12 | 2.14 | Full Range 1.7 to 2.7 | mg/dL |
| Evaluation of Effect of Repeated SC Injections of KRN23 | KRN23 | Visit 6 (D18)/18 | 2.15 | Full Range 1.7 to 3.0 | mg/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01340482/results